TY - JOUR PY - 2023// TI - Global prevalence of suicide in patients with cancer: a systematic review and meta-analysis JO - Archives of suicide research A1 - Rafiei, Sima A1 - Pashazadeh Kan, Fatemeh A1 - Raoofi, Samira A1 - Shafiee, Farnoosh A1 - Masoumi, Maryam A1 - Bagheribayati, Farzaneh A1 - Javan Biparva, Akbar A1 - Noorani Mejareh, Zahra A1 - Sanaei, Mohaddeseh A1 - Dolati, Yasamin A1 - Abdollahi, Bahare A1 - Khani, Saghar A1 - Parnian, Elaheh A1 - Nosrati Sanjabad, Elmira A1 - Ghashghaee, Ahmad SP - ePub EP - ePub VL - ePub IS - ePub N2 - AIM: Given that patients with cancer may commit suicide due to physical and mental problems, the present study objectives were to identify particular risk factors of different subgroup of patients including type of cancer, gender, age, type and time of suicide, and geographical region to facilitate early care and psychosocial support.

METHODS: A comprehensive review of databases including Embase, Scopus, PubMed, and Web of Science was conducted for original articles published in English from January 2000 to March 2022. It is based on the PRISMA checklist.

RESULTS: After reviewing 69 articles selected from 15 countries, the total prevalence rate of suicide among 34,157,856 patients with cancer was estimated 67,169, at 0.013 (95% CI, 0.008-0.021). The highest suicide prevalence was related to gastrointestinal cancer, estimated at 0.204 (95% CI, 0.161-0.255). A gender-based meta-analysis showed that the prevalence of suicide/suicidal ideation was higher among men, estimated at 0.013 (95% CI, 0.008-0.023) compared with women, at 0.006 (95% CI, 0.002-0.017).

CONCLUSION: Based on study results, suicide-prevention strategies should be aimed at patients younger than 40 years of age to effectively resolve their mental health disorders and promote their self-efficacy in successful management of the disease.

Language: en

LA - en SN - 1381-1118 UR - http://dx.doi.org/10.1080/13811118.2023.2240870 ID - ref1 ER -